Table: Phoenixbio -Q1 group results

PhoenixBio

13/08/2024 07:30

Aug 13 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              449 mln             439 mln           2.12     
                   (+2.3 pct)          (-1.3 pct)       (+23.7 pct) 
  Operating           5 mln               7 mln           214 mln   
                   (-16.9 pct)         (-92.1 pct)                  
  Recurring          25 mln              47 mln           214 mln   
                   (-47.1 pct)         (-58.2 pct)     (+393.6 pct) 
  Net                23 mln              42 mln           201 mln   
                   (-45.0 pct)         (-59.3 pct)     (+662.3 pct) 
  EPS               5.75 yen            11.59 yen        49.92 yen  
  EPS Diluted                           8.01 yen                    
  Ann Div                                  NIL              NIL     
  -Q2 div                                  NIL              NIL     
  -Q4 div                                  NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T